Personalized Treatment Approach to Metastatic Castration-Resistant Prostate Cancer with BRCA2 and PTEN Mutations: A Case Report

DNA repair mutations (BRCA1 and BRCA2) are found in metastatic castration-resistant prostate cancer (CRPC) patients. Here, we report a case of a 71-year-old male patient with metastatic CRPC along with BRCA2 and PTEN mutations. As per the genomic findings of the Foundation One report, FDA-approved t...

Descripción completa

Detalles Bibliográficos
Autores principales: Julka, Pramod Kumar, Verma, Amit, Gupta, Kush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036550/
https://www.ncbi.nlm.nih.gov/pubmed/32110220
http://dx.doi.org/10.1159/000505182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036550/
https://www.ncbi.nlm.nih.gov/pubmed/32110220
http://dx.doi.org/10.1159/000505182

Ejemplares similares